glp-1 who should not take Why I'm Choosing to GLP-1s, Even Though Everyone Expects Me To who should not take glp
Description
The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course
Available in Two Sizes: 1-Pack (30 patches): Compact and convenient for customers seeking a simple daily solution, priced at $8.99
How to make protein the first thing eaten at every small meal when appetite is low
GLP-1s are becoming a bigger part of weight management
But we know there are a lot of Old Bulls on it or considering it
A Saxenda generic is now available as liraglutide for weight management
